CLOE logo

Clover Leaf Capital Corp. (CLOE) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Clover Leaf Capital Corp. (CLOE) opera en el sector Financial Services, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 44/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 44/100

Clover Leaf Capital Corp. (CLOE) Perfil de Servicios Financieros

CEOFelipe MacLean
Empleados3
Sede CentralMiami, US
Año de la oferta pública inicial (OPI)2021

Clover Leaf Capital Corp., a shell company incorporated in 2021, seeks a merger, acquisition, or similar business combination within the cannabis sector. Operating with minimal staff and no current revenue, the company's future hinges on identifying and completing a successful transaction in a competitive market.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Clover Leaf Capital Corp.'s investment thesis hinges on its ability to identify and successfully merge with or acquire a promising business within the cannabis industry. With a market capitalization of $0.06 billion and a negative P/E ratio of -68.30, the company's valuation is speculative and dependent on future deal-making. A successful acquisition could drive significant shareholder value. However, the company faces risks associated with regulatory uncertainty, competition in the cannabis sector, and the inherent challenges of completing a business combination. Investors should closely monitor the company's progress in identifying and executing a transaction, as well as the financial performance of any acquired entity.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.06 billion indicates a small-cap company with potential for growth but also higher risk.
  • Negative P/E ratio of -68.30 reflects the company's current lack of profitability and reliance on future transactions.
  • Beta of 0.07 suggests low volatility compared to the overall market, potentially due to its inactive operational status.
  • No dividend yield reflects the company's focus on reinvesting capital for growth rather than returning it to shareholders.
  • Focus on the cannabis industry provides exposure to a high-growth sector, but also exposes the company to regulatory and competitive risks.

Competidores y Pares

Fortalezas

  • Focus on the high-growth cannabis industry.
  • Experienced management team with deal-making expertise.
  • Access to capital markets for funding acquisitions.
  • Flexibility to pursue a variety of business combinations.

Debilidades

  • Lack of current revenue-generating operations.
  • Dependence on identifying and completing a successful acquisition.
  • Small size and limited resources.
  • Exposure to regulatory and competitive risks in the cannabis industry.

Catalizadores

  • Upcoming: Announcement of a potential merger or acquisition target within the cannabis industry.
  • Ongoing: Progress in negotiations with potential acquisition targets.
  • Ongoing: Changes in cannabis regulations that could benefit the company.
  • Ongoing: Capital raising efforts to fund acquisitions.

Riesgos

  • Potential: Failure to identify and complete a successful acquisition.
  • Potential: Regulatory uncertainty in the cannabis industry.
  • Potential: Intense competition from other cannabis companies.
  • Ongoing: Limited financial disclosure and low trading volume due to OTC listing.
  • Ongoing: Dependence on the success of the cannabis industry.

Oportunidades de crecimiento

  • Growth opportunity 1: Successful Merger or Acquisition: Clover Leaf's primary growth opportunity lies in successfully merging with or acquiring a promising cannabis business. The global legal cannabis market is projected to reach $57 billion by 2027, presenting a significant opportunity for growth. A well-chosen target could provide Clover Leaf with immediate revenue, market share, and growth potential. The timeline for this opportunity is dependent on the company's ability to identify and close a deal, which could occur within the next 12-24 months.
  • Growth opportunity 2: Capitalizing on Cannabis Industry Growth: The cannabis industry is experiencing rapid expansion, driven by increasing legalization and consumer demand. Clover Leaf can capitalize on this trend by acquiring or merging with a company that is well-positioned to benefit from this growth. This includes companies involved in cultivation, processing, distribution, or retail of cannabis products. The timeline for this opportunity is ongoing, as the cannabis industry continues to evolve and expand.
  • Growth opportunity 3: Geographic Expansion: Clover Leaf could pursue growth by expanding its operations into new geographic markets. As more countries and states legalize cannabis, there will be opportunities to acquire or merge with companies that have a strong presence in these emerging markets. This could involve expanding into new states within the US or entering international markets such as Canada, Europe, or Latin America. The timeline for this opportunity is dependent on the pace of cannabis legalization globally.
  • Growth opportunity 4: Product Diversification: Clover Leaf could diversify its product offerings by acquiring or merging with a company that specializes in a particular segment of the cannabis market, such as edibles, concentrates, or CBD products. This would allow the company to expand its customer base and reduce its reliance on any single product category. The timeline for this opportunity is ongoing, as the cannabis market continues to evolve and new product categories emerge.
  • Growth opportunity 5: Strategic Partnerships: Clover Leaf can pursue growth through strategic partnerships with other companies in the cannabis industry. This could involve partnering with companies that have complementary expertise or resources, such as cultivation facilities, distribution networks, or retail outlets. These partnerships can help Clover Leaf to expand its reach, improve its efficiency, and reduce its risk. The timeline for this opportunity is ongoing, as the company seeks to build relationships with key players in the cannabis industry.

Oportunidades

  • Increasing legalization of cannabis in new markets.
  • Growing demand for cannabis products.
  • Consolidation in the cannabis industry.
  • Emergence of new cannabis-related technologies and products.

Amenazas

  • Regulatory uncertainty in the cannabis industry.
  • Intense competition from other cannabis companies.
  • Fluctuations in cannabis prices.
  • Changes in consumer preferences.

Ventajas competitivas

  • First-mover advantage in identifying and acquiring promising cannabis businesses.
  • Expertise in structuring and negotiating complex business combinations.
  • Access to capital markets to fund acquisitions.
  • Network of relationships within the cannabis industry.

Acerca de CLOE

Clover Leaf Capital Corp., established in 2021 and based in Miami, Florida, operates as a shell company with the primary objective of executing a business combination. This includes mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar transactions. The company's strategic focus is centered on identifying and partnering with businesses operating within the cannabis industry. As a shell company, Clover Leaf Capital Corp. currently has no significant revenue-generating operations. Its activities are primarily directed toward due diligence, negotiation, and structuring a potential deal. The success of Clover Leaf Capital Corp. depends heavily on its ability to find a suitable target company within the cannabis sector and successfully complete a transaction that creates value for its shareholders. The company's small size, with only three employees, reflects its early stage and limited operational scope. The cannabis industry focus presents both opportunities and challenges, given the evolving regulatory landscape and increasing competition within the sector. Clover Leaf Capital Corp. is navigating a complex environment as it seeks to establish a foothold through strategic partnerships or acquisitions.

Qué hacen

  • Seeks to merge with or acquire a company.
  • Focuses on businesses in the cannabis industry.
  • Evaluates potential target companies.
  • Negotiates terms of business combinations.
  • Raises capital to fund acquisitions.
  • Manages the integration of acquired businesses.

Modelo de Negocio

  • Identifies and evaluates potential acquisition targets in the cannabis industry.
  • Structures and negotiates business combination agreements.
  • Raises capital through debt or equity financing to fund acquisitions.
  • Generates returns for shareholders through appreciation in the value of the combined entity.

Contexto de la Industria

Clover Leaf Capital Corp. operates within the shell company segment of the financial services sector, specifically targeting the cannabis industry. The shell company landscape is characterized by intense competition and regulatory scrutiny. The cannabis industry itself is experiencing rapid growth, driven by increasing legalization and consumer demand. However, it also faces regulatory hurdles and market volatility. Clover Leaf's success depends on its ability to navigate this complex environment and identify a high-potential target company.

Clientes Clave

  • Shareholders seeking exposure to the cannabis industry.
  • Potential target companies in the cannabis sector looking for capital and strategic partnerships.
  • Investors in the cannabis industry looking for investment opportunities.
Confianza de la IA: 79% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Clover Leaf Capital Corp. (CLOE): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para CLOE.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CLOE.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CLOE.

MoonshotScore

44/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CLOE en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Felipe MacLean

CEO

Felipe MacLean is the CEO of Clover Leaf Capital Corp. His background includes experience in financial services and investment management. He has a track record of identifying and executing successful business transactions. MacLean's expertise lies in deal structuring, capital raising, and strategic planning. His leadership is focused on driving shareholder value through strategic acquisitions and partnerships.

Historial: Under Felipe MacLean's leadership, Clover Leaf Capital Corp. has focused on identifying potential merger and acquisition targets within the cannabis industry. While the company has not yet completed a transaction, MacLean has overseen the due diligence process and negotiations with several potential targets. His strategic decisions have been centered on maximizing shareholder value through a well-chosen acquisition.

Información del mercado OTC de CLOE

The OTC Other tier represents the lowest tier of the OTC market, indicating that Clover Leaf Capital Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and prospects. Trading on the OTC Other tier carries higher risks compared to exchanges like NYSE or NASDAQ due to less stringent listing requirements and potentially lower liquidity.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity in OTC Other stocks can be highly variable and often limited. Bid-ask spreads can be wide, and it may be difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should be prepared for potential difficulty in trading CLOE due to its OTC listing and the potential for low trading volume.
Factores de riesgo OTC:
  • Limited financial disclosure increases the risk of investing in CLOE.
  • Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
  • OTC Other stocks are subject to less regulatory oversight than exchange-listed stocks.
  • The company's ability to complete a successful acquisition is uncertain.
  • The cannabis industry is subject to regulatory and competitive risks.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the management team.
  • Assess the company's business plan and prospects for growth.
  • Evaluate the risks associated with the cannabis industry.
  • Understand the terms of any potential acquisition or merger.
  • Monitor the company's trading volume and price volatility.
  • Consult with a financial advisor before investing.
Señales de legitimidad:
  • Company is registered and incorporated in the United States.
  • Management team has experience in financial services and investment management.
  • Company has a clear strategic focus on the cannabis industry.
  • Company has identified potential acquisition targets.
  • Company is actively seeking to raise capital to fund acquisitions.

Lo Que los Inversores Preguntan Sobre Clover Leaf Capital Corp. (CLOE)

¿Cuáles son los factores clave para evaluar CLOE?

Clover Leaf Capital Corp. (CLOE) actualmente tiene una puntuación IA de 44/100, indicando puntuación baja. Fortaleza clave: Focus on the high-growth cannabis industry.. Riesgo principal a monitorear: Potential: Failure to identify and complete a successful acquisition.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CLOE?

CLOE actualmente puntúa 44/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CLOE?

Los precios de CLOE se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CLOE?

La cobertura de analistas para CLOE incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CLOE?

Las categorías de riesgo para CLOE incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Failure to identify and complete a successful acquisition.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CLOE?

La relación P/E para CLOE compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CLOE sobrevalorada o infravalorada?

Determinar si Clover Leaf Capital Corp. (CLOE) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CLOE?

Clover Leaf Capital Corp. (CLOE) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on publicly available sources and may be subject to change.
  • The company is a shell company with no significant operations, which increases the risk of investing.
  • The cannabis industry is subject to regulatory and competitive risks.
Fuentes de datos

Popular Stocks